Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial

Christianne N. Heck, David King-Stephens, Andrew D. Massey, Dileep R. Nair, Barbara C. Jobst, Gregory L. Barkley, Vicenta Salanova, Andrew J. Cole, Michael C. Smith, Ryder P. Gwinn, Christopher Skidmore, Paul C. Van Ness, Gregory K. Bergey, Yong D. Park, Ian Miller, Eric Geller, Paul A. Rutecki, Richard Zimmerman, David C. Spencer, Alica GoldmanJonathan C. Edwards, James W. Leiphart, Robert E. Wharen, James Fessler, Nathan B. Fountain, Gregory A. Worrell, Robert E. Gross, Stephan Eisenschenk, Robert B. Duckrow, Lawrence J. Hirsch, Carl Bazil, Cormac A. O'Donovan, Felice T. Sun, Tracy A. Courtney, Cairn G. Seale, Martha J. Morrell

Research output: Contribution to journalArticle

263 Scopus citations

Abstract

Objective To demonstrate the safety and effectiveness of responsive stimulation at the seizure focus as an adjunctive therapy to reduce the frequency of seizures in adults with medically intractable partial onset seizures arising from one or two seizure foci. Methods Randomized multicenter double-blinded controlled trial of responsive focal cortical stimulation (RNS System). Subjects with medically intractable partial onset seizures from one or two foci were implanted, and 1 month postimplant were randomized 1:1 to active or sham stimulation. After the fifth postimplant month, all subjects received responsive stimulation in an open label period (OLP) to complete 2 years of postimplant follow-up. Results All 191 subjects were randomized. The percent change in seizures at the end of the blinded period was -37.9% in the active and -17.3% in the sham stimulation group (p = 0.012, Generalized Estimating Equations). The median percent reduction in seizures in the OLP was 44% at 1 year and 53% at 2 years, which represents a progressive and significant improvement with time (p < 0.0001). The serious adverse event rate was not different between subjects receiving active and sham stimulation. Adverse events were consistent with the known risks of an implanted medical device, seizures, and of other epilepsy treatments. There were no adverse effects on neuropsychological function or mood. Significance Responsive stimulation to the seizure focus reduced the frequency of partial-onset seizures acutely, showed improving seizure reduction over time, was well tolerated, and was acceptably safe. The RNS System provides an additional treatment option for patients with medically intractable partial-onset seizures.

Original languageEnglish (US)
Pages (from-to)432-441
Number of pages10
JournalEpilepsia
Volume55
Issue number3
DOIs
StatePublished - Jan 1 2014

Keywords

  • Cortical stimulation
  • Focal seizures
  • Neurostimulator
  • Partial seizures
  • Responsive stimulation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint Dive into the research topics of 'Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial'. Together they form a unique fingerprint.

  • Cite this

    Heck, C. N., King-Stephens, D., Massey, A. D., Nair, D. R., Jobst, B. C., Barkley, G. L., Salanova, V., Cole, A. J., Smith, M. C., Gwinn, R. P., Skidmore, C., Van Ness, P. C., Bergey, G. K., Park, Y. D., Miller, I., Geller, E., Rutecki, P. A., Zimmerman, R., Spencer, D. C., ... Morrell, M. J. (2014). Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial. Epilepsia, 55(3), 432-441. https://doi.org/10.1111/epi.12534